Co-hosted by MIT Institute Professors Phil Sharp (Nobel laureate and co-founder, Biogen & Alnylam) and Bob Langer (NAS, co-founder, Moderna & Momenta), Longwood Healthcare Leaders Spring MIT brings together leaders in biotech and pharma for two days of discussion and senior-level networking with a sophisticated C-suite executive audience. Join top biotech and pharma CEOs, heads of R&D and BD, life science investors, key government officials and leading researchers for two days of fireside chats and themed discussion panels on a variety of the most important topics facing our industry today.

See Agenda
Reserve Your Spot

Featured Speakers

Regulatory & Public Policy Leaders 

Jake Auchincloss

U.S. Representative

Commonwealth of Massachusetts

Victor Dzau

President

National Academy of Medicine



Peter Hutt

former General Counsel

FDA


Peter Marks

Director, CBER

FDA






Rochelle Walensky

Director

CDC (2021-2023)




Academia & Research

Laurie Glimcher

CEO

Dana-Farber Cancer Institute



Anne Klibanski

President & CEO

Mass General Brigham



Sally Kornbluth

President

MIT




Bob Langer

Institute Professor

MIT




Phil Sharp

Institute Professor, MIT;

Co-Founder,

Biogen

BioPharma CEOs

Ivan Cheung

CEO

NextPoint Therapeutics



Marianne De Backer

CEO

Vir Bio



Brian Goff

CEO

Agios





Sek Kathiresan

CEO

Verve Therapeutics





Ed Kaye

CEO

Stoke Therapeutics





Jeb Keiper

CEO

Nimbus Therapeutics

Mathai Mammen

CEO

FogPharma



Christopher Viehbacher

CEO

Biogen

Christophe Weber

CEO

Takeda



Leslie Williams

CEO

hC Bioscience



Pharma R&D Leaders

Johanna Bendell

Global Head Oncology, Pharma Research & Early Development

Roche

Mikael Dolsten

CSO & President, WWR&D Medical

Pfizer




Andy Plump

President, R&D

Takeda



Dave Reese

Chief Technology Officer

Amgen





Priya Singhal

EVP, Head, Development

Biogen





BD & Strategy Leaders

Stephen Hoge

President

Moderna




Rachid Izzar

EVP, Head, Global Product Strategy & Commercialization

Biogen

Raj Prasad

CFO

Crispr Therapeutics



Deniz Razon

CBO

Servier Pharmaceuticals



Jim Reddoch

EVP, Investments

& CSO

Royalty Pharma



Cocktail Reception

Meeting participants will enjoy multiple networking opportunities including a lively cocktail reception

Monday, June 17, 5-7pm

See Agenda
Reserve Your Spot

Topics

  • (Big Bio)Pharma Pipeline Sourcing
  • Translating Science into Medicine
  • Driving Productivity in R&D
  • Regulatory & Industry Roundtable
  • Targeted Licensing & Acquisitions
  • Innovation in Drug Discovery
  • The Future of Mental Healthcare
  • Navigating Partnerships Across Borders
  • Investment Outlook
  • Ecosystem of External Innovation
  • Accelerating Drug Development
  • Getting to Regulatory Approval
  • Innovative Commercial Models
  • Maintaining Patient-Centric Focus
  • Developing a Strong Syndicate
  • Identifying Next-Generation Therapeutics
  • Innovation in Clinical Trials
  • Managing the Runway
  • Platform to Pipeline
  • Advancing Late State Assets
  • Ensuring Health Equity & Access
  • R&D Collaboration

Supporters

To learn more about getting involved, contact sg@longwoodfund.com

Become a Supporter
LHCL Logo Transparent.png

#LongwoodHealthcareLeaders

Upcoming Conferences:

Spring MIT: June 17-18, 2024

Boston CEO: October 2024

San Francisco CEO: January 11-12, 2025

Miami CEO 2025: April 9 - 11, 2025

LinkedIn  Twitter